NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Collector’s Universe, Inc. (NASDAQ: CLCT) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by an investor group led by Nat Turner, D1 Capital Partners, L.P., and Cohen Private Ventures, LLC (the “Investor Group”).
Click here to learn more and participate in the action.
On November 30, 2020, Collector’s Universe announced that it had signed an agreement to be acquired by the Investor Group for approximately $700 million. Pursuant to the merger agreement, Collector’s Universe stockholders will receive $75.25 in cash for each share of Collector’s Universe common stock owned. The deal is scheduled to close in the first quarter of 2021.
Bragar Eagel & Squire is concerned that Collector’s Universe’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Collector’s Universe’s stockholders.
If you own shares of Collector’s Universe and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Melissa Fortunato or Alexandra Raymond by email at firstname.lastname@example.org or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.